Federal contractors lost not only wages during the 5-week government shutdown, some of them also lost health insurance; with advances in gene therapy, scientists are beginning to talk about a cure in sickle cell disease; there’s bipartisan interest in attacking the issue of unexpected medical bills, and the effort has been aided by President Donald Trump, who voiced support last week for protecting patients.
Federal contractors lost not only wages during the 5-week government shutdown, some of them lost health insurance, The Washington Post reported. The paper detailed how 1 government contractor was unable to pay the $60,000 premium to CareFirst BlueCross BlueShield, leaving employees and their families, some of whom have delayed medical care, with financial liabilities.
With advances in gene therapy, scientists are beginning to talk about a cure in sickle cell disease, The New York Times reported. In a half-dozen clinical trials planned or underway, researchers are testing strategies for correcting the problem at the genetic level. While a handful of the enrolled patients no longer show signs of the disease, it is still early in the course of these experimental treatments, and it is likely to be at least 3 years before one is approved.
There’s bipartisan interest in attacking the issue of unexpected medical bills, and the effort has been aided by President Donald Trump, who voiced support last week for protecting patients, The Hill reported. The effort faces obstacles from powerful healthcare industry groups, which want to ensure that they avoid a financial hit from whatever solution lawmakers and the White House put forth.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen